Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 4/2016

25.01.2016 | Original Article

Improved detection of deeply invasive candidiasis with DNA aptamers specific binding to (1→3)-β-D-glucans from Candida albicans

verfasst von: X.-L. Tang, Y. Hua, Q. Guan, C.-H. Yuan

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Deeply invasive or disseminated candidiasis is a serious and often fatal complication that can occur frequently in immuno-compromised individuals. However, conventional diagnostic methods of Candida albicans display low sensitivity and lack of specificity; the development of rapid and accurate detection methods remains a high priority. Aptamers are single-strand DNA or RNA oligonucleotides that specifically bind to target molecules with high affinity. In this study, we sought to screen high-affinity DNA aptamers that specifically bound to (1→3)-β-D-glucans from cell wall of Candida albicans using a systematic evolution of ligands by exponential enrichment (SELEX) technique, and further evaluate the diagnostic potential for invasive or disseminated candidiasis with selected aptamers. (1→3)-β-D-glucans was purified from Candida albicans, and two single DNA aptamers (designated as AU1 and AD1) were selected. Analysis of dissociation constants and binding domains further revealed that these two selected single DNA aptamers (AU1 and AD1) showed high binding affinity (AD1: Kd = 79.76 nM, AD1: Kd = 103.7 nM) and did not bind to the same domain of (1→3)-β-D-glucans. Next, we further detected (1→3)-β-D-glucans in serum samples from different groups of patients with Candida albicans infection or simple bacterial infection by using a double-aptamer sandwich enzyme-linked oligonucleotide assay (ELONA). The results showed that the sensitivity and specificity of this aptamer-based sandwich ELONA were 92.31 % and 91.94 % respectively. Thus, our study suggests that AU1 and AD1 have potential application for the differentiate diagnosis of deeply invasive candidiasis and provide valuable clues for designing diagnostic agents for the identification of invasive fungal infection.
Literatur
1.
2.
3.
Zurück zum Zitat Wahyuningsih R, Freisleben HJ, Sonntag HG, Schnitzler P (2000) Simple and rapid detection of Candida albicans DNA in serum by PCR for diagnosis of invasive candidiasis. J Clin Microbiol 38(8):3016–3021PubMedPubMedCentral Wahyuningsih R, Freisleben HJ, Sonntag HG, Schnitzler P (2000) Simple and rapid detection of Candida albicans DNA in serum by PCR for diagnosis of invasive candidiasis. J Clin Microbiol 38(8):3016–3021PubMedPubMedCentral
4.
Zurück zum Zitat Ha JF, Italiano CM, Heath CH, Shih S, Rea S, Wood FM (2011) Candidemia and invasive candidiasis: a review of the literature for the burns surgeon. Burns: J Int Soc Burn Inj 37(2):181–195CrossRef Ha JF, Italiano CM, Heath CH, Shih S, Rea S, Wood FM (2011) Candidemia and invasive candidiasis: a review of the literature for the burns surgeon. Burns: J Int Soc Burn Inj 37(2):181–195CrossRef
5.
Zurück zum Zitat Cavalheiro RA, Fortes F, Borecky J, Faustinoni VC, Schreiber AZ, Vercesi AE (2004) Respiration, oxidative phosphorylation, and uncoupling protein in Candida albicans. Braz J Med Biol Res 37(10):1455–1461CrossRefPubMed Cavalheiro RA, Fortes F, Borecky J, Faustinoni VC, Schreiber AZ, Vercesi AE (2004) Respiration, oxidative phosphorylation, and uncoupling protein in Candida albicans. Braz J Med Biol Res 37(10):1455–1461CrossRefPubMed
6.
Zurück zum Zitat Tragiannidis A, Tsoulas C, Groll AH (2015) Invasive candidiasis and candidaemia in neonates and children: update on current guidelines. Mycoses 58(1):10–21CrossRefPubMed Tragiannidis A, Tsoulas C, Groll AH (2015) Invasive candidiasis and candidaemia in neonates and children: update on current guidelines. Mycoses 58(1):10–21CrossRefPubMed
7.
Zurück zum Zitat Botero-Calderon L, Benjamin DK Jr, Cohen-Wolkowiez M (2015) Advances in the treatment of invasive neonatal candidiasis. Expert Opin Pharmacother 16(7):1035–1048CrossRefPubMed Botero-Calderon L, Benjamin DK Jr, Cohen-Wolkowiez M (2015) Advances in the treatment of invasive neonatal candidiasis. Expert Opin Pharmacother 16(7):1035–1048CrossRefPubMed
8.
Zurück zum Zitat Eraso E, Moragues MD, Villar-Vidal M, Sahand IH, Gonzalez-Gomez N, Ponton J, Quindos G (2006) Evaluation of the new chromogenic medium Candida ID 2 for isolation and identification of Candida albicans and other medically important Candida species. J Clin Microbiol 44(9):3340–3345CrossRefPubMedPubMedCentral Eraso E, Moragues MD, Villar-Vidal M, Sahand IH, Gonzalez-Gomez N, Ponton J, Quindos G (2006) Evaluation of the new chromogenic medium Candida ID 2 for isolation and identification of Candida albicans and other medically important Candida species. J Clin Microbiol 44(9):3340–3345CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Okulicz JF, Rivard RG, Conger NG, Nguyen MX, Hospenthal DR (2008) Primary isolation of Candida species from urine specimens using chromogenic medium. Mycoses 51(2):141–146CrossRefPubMed Okulicz JF, Rivard RG, Conger NG, Nguyen MX, Hospenthal DR (2008) Primary isolation of Candida species from urine specimens using chromogenic medium. Mycoses 51(2):141–146CrossRefPubMed
10.
Zurück zum Zitat Villamizar RA, Maroto A, Rius FX (2009) Improved detection of Candida albicans with carbon nanotube field-effect transistors. Sensors Actuators B Chem 136(2):451–457CrossRef Villamizar RA, Maroto A, Rius FX (2009) Improved detection of Candida albicans with carbon nanotube field-effect transistors. Sensors Actuators B Chem 136(2):451–457CrossRef
11.
Zurück zum Zitat Scheld WM, Brown RS Jr, Harding SA, Sande MA (1980) Detection of circulating antigen in experimental Candida albicans endocarditis by an enzyme-linked immunosorbent assay. J Clin Microbiol 12(5):679–683PubMedPubMedCentral Scheld WM, Brown RS Jr, Harding SA, Sande MA (1980) Detection of circulating antigen in experimental Candida albicans endocarditis by an enzyme-linked immunosorbent assay. J Clin Microbiol 12(5):679–683PubMedPubMedCentral
12.
Zurück zum Zitat Clancy CJ, Nguyen ML, Cheng S, Huang H, Fan G, Jaber RA, Wingard JR, Cline C, Nguyen MH (2008) Immunoglobulin G responses to a panel of Candida albicans antigens as accurate and early markers for the presence of systemic candidiasis. J Clin Microbiol 46(5):1647–1654CrossRefPubMedPubMedCentral Clancy CJ, Nguyen ML, Cheng S, Huang H, Fan G, Jaber RA, Wingard JR, Cline C, Nguyen MH (2008) Immunoglobulin G responses to a panel of Candida albicans antigens as accurate and early markers for the presence of systemic candidiasis. J Clin Microbiol 46(5):1647–1654CrossRefPubMedPubMedCentral
13.
14.
Zurück zum Zitat Fortun J, Meije Y, Buitrago MJ, Gago S, Bernal-Martinez L, Peman J, Perez M, Gomez GPE, Madrid N, Pintado V, Martin-Davila P, Cobo J, Fresco G, Moreno S, Cuenca-Estrella M (2014) Clinical validation of a multiplex real-time PCR assay for detection of invasive candidiasis in intensive care unit patients. J Antimicrob Chemother 69(11):3134–3141CrossRefPubMed Fortun J, Meije Y, Buitrago MJ, Gago S, Bernal-Martinez L, Peman J, Perez M, Gomez GPE, Madrid N, Pintado V, Martin-Davila P, Cobo J, Fresco G, Moreno S, Cuenca-Estrella M (2014) Clinical validation of a multiplex real-time PCR assay for detection of invasive candidiasis in intensive care unit patients. J Antimicrob Chemother 69(11):3134–3141CrossRefPubMed
15.
Zurück zum Zitat Low SY, Hill JE, Peccia J (2009) DNA aptamers bind specifically and selectively to (1-->3)-beta-D-glucans. Biochem Biophys Res Commun 378(4):701–705CrossRefPubMedPubMedCentral Low SY, Hill JE, Peccia J (2009) DNA aptamers bind specifically and selectively to (1-->3)-beta-D-glucans. Biochem Biophys Res Commun 378(4):701–705CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Ohno N (2003) Chemistry and biology of angiitis inducer, Candida albicans water-soluble mannoprotein-beta-glucan complex (CAWS). Microbiol Immunol 47(7):479–490CrossRefPubMed Ohno N (2003) Chemistry and biology of angiitis inducer, Candida albicans water-soluble mannoprotein-beta-glucan complex (CAWS). Microbiol Immunol 47(7):479–490CrossRefPubMed
17.
Zurück zum Zitat Alexander BD, Smith PB, Davis RD, Perfect JR, Reller LB (2010) The (1,3){beta}-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation. J Clin Microbiol 48(11):4083–4088CrossRefPubMedPubMedCentral Alexander BD, Smith PB, Davis RD, Perfect JR, Reller LB (2010) The (1,3){beta}-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation. J Clin Microbiol 48(11):4083–4088CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Ostrosky-Zeichner L, Alexander BD, Kett DH, Vazquez J, Pappas PG, Saeki F, Ketchum PA, Wingard J, Schiff R, Tamura H, Finkelman MA, Rex JH (2005) Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis: Off Publ Infect Dis Soc Am 41(5):654–659CrossRef Ostrosky-Zeichner L, Alexander BD, Kett DH, Vazquez J, Pappas PG, Saeki F, Ketchum PA, Wingard J, Schiff R, Tamura H, Finkelman MA, Rex JH (2005) Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis: Off Publ Infect Dis Soc Am 41(5):654–659CrossRef
19.
Zurück zum Zitat Odabasi Z, Mattiuzzi G, Estey E, Kantarjian H, Saeki F, Ridge RJ, Ketchum PA, Finkelman MA, Rex JH, Ostrosky-Zeichner L (2004) Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 39(2):199–205CrossRefPubMed Odabasi Z, Mattiuzzi G, Estey E, Kantarjian H, Saeki F, Ridge RJ, Ketchum PA, Finkelman MA, Rex JH, Ostrosky-Zeichner L (2004) Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 39(2):199–205CrossRefPubMed
20.
Zurück zum Zitat Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD, Infectious Diseases Society of A (2009) Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48(5):503–535CrossRefPubMed Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD, Infectious Diseases Society of A (2009) Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48(5):503–535CrossRefPubMed
21.
Zurück zum Zitat Douwes J (2005) (1-->3)-Beta-D-glucans and respiratory health: a review of the scientific evidence. Indoor Air 15(3):160–169CrossRefPubMed Douwes J (2005) (1-->3)-Beta-D-glucans and respiratory health: a review of the scientific evidence. Indoor Air 15(3):160–169CrossRefPubMed
22.
Zurück zum Zitat Foto M, Plett J, Berghout J, Miller JD (2004) Modification of the Limulus amebocyte lysate assay for the analysis of glucan in indoor environments. Anal Bioanal Chem 379(1):156–162CrossRefPubMed Foto M, Plett J, Berghout J, Miller JD (2004) Modification of the Limulus amebocyte lysate assay for the analysis of glucan in indoor environments. Anal Bioanal Chem 379(1):156–162CrossRefPubMed
23.
Zurück zum Zitat Varelas V, Liouni M, Calokerinos AC, Nerantzis ET (2015) An evaluation study of different methods for the production of beta-D-glucan from yeast biomass. Drug Test Anal Varelas V, Liouni M, Calokerinos AC, Nerantzis ET (2015) An evaluation study of different methods for the production of beta-D-glucan from yeast biomass. Drug Test Anal
24.
Zurück zum Zitat Tang XL, Zhou YX, Wu SM, Pan Q, Xia B, Zhang XL (2014) CFP10 and ESAT6 aptamers as effective mycobacterial antigen diagnostic reagents. J Infect 69(6):569–580CrossRefPubMed Tang XL, Zhou YX, Wu SM, Pan Q, Xia B, Zhang XL (2014) CFP10 and ESAT6 aptamers as effective mycobacterial antigen diagnostic reagents. J Infect 69(6):569–580CrossRefPubMed
25.
Zurück zum Zitat Allen CM (1994) Animal models of oral candidiasis. A review. Oral Surg Oral Med Oral Pathol 78(2):216–221CrossRefPubMed Allen CM (1994) Animal models of oral candidiasis. A review. Oral Surg Oral Med Oral Pathol 78(2):216–221CrossRefPubMed
26.
Zurück zum Zitat Conti HR, Huppler AR, Whibley N, Gaffen SL (2014) Animal models for candidiasis. Curr Protoc Immunol 105:19.6.11–19.6.17 Conti HR, Huppler AR, Whibley N, Gaffen SL (2014) Animal models for candidiasis. Curr Protoc Immunol 105:19.6.11–19.6.17
27.
Zurück zum Zitat Pazos C, Ponton J, Del Palacio A (2005) Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol 43(1):299–305CrossRefPubMedPubMedCentral Pazos C, Ponton J, Del Palacio A (2005) Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol 43(1):299–305CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Kondori N, Edebo L, Mattsby-Baltzer I (2004) Circulating beta (1-3) glucan and immunoglobulin G subclass antibodies to Candida albicans cell wall antigens in patients with systemic candidiasis. Clin Diagn Lab Immunol 11(2):344–350PubMedPubMedCentral Kondori N, Edebo L, Mattsby-Baltzer I (2004) Circulating beta (1-3) glucan and immunoglobulin G subclass antibodies to Candida albicans cell wall antigens in patients with systemic candidiasis. Clin Diagn Lab Immunol 11(2):344–350PubMedPubMedCentral
29.
Zurück zum Zitat Guery BP, Arendrup MC, Auzinger G, Azoulay E, Borges Sa M, Johnson EM, Muller E, Putensen C, Rotstein C, Sganga G, Venditti M, Zaragoza Crespo R, Kullberg BJ (2009) Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis. Intensive Care Med 35(1):55–62CrossRefPubMed Guery BP, Arendrup MC, Auzinger G, Azoulay E, Borges Sa M, Johnson EM, Muller E, Putensen C, Rotstein C, Sganga G, Venditti M, Zaragoza Crespo R, Kullberg BJ (2009) Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis. Intensive Care Med 35(1):55–62CrossRefPubMed
30.
Zurück zum Zitat Kullberg BJ, Verweij PE, Akova M, Arendrup MC, Bille J, Calandra T, Cuenca-Estrella M, Herbrecht R, Jacobs F, Kalin M, Kibbler CC, Lortholary O, Martino P, Meis JF, Munoz P, Odds FC, De Pauw BE, Rex JH, Roilides E, Rogers TR, Ruhnke M, Ullmann AJ, Uzun O, Vandewoude K, Vincent JL, Donnelly JP (2011) European expert opinion on the management of invasive candidiasis in adults. Clin Microbiol Infect 17(Suppl 5):1–12CrossRefPubMed Kullberg BJ, Verweij PE, Akova M, Arendrup MC, Bille J, Calandra T, Cuenca-Estrella M, Herbrecht R, Jacobs F, Kalin M, Kibbler CC, Lortholary O, Martino P, Meis JF, Munoz P, Odds FC, De Pauw BE, Rex JH, Roilides E, Rogers TR, Ruhnke M, Ullmann AJ, Uzun O, Vandewoude K, Vincent JL, Donnelly JP (2011) European expert opinion on the management of invasive candidiasis in adults. Clin Microbiol Infect 17(Suppl 5):1–12CrossRefPubMed
31.
Zurück zum Zitat Charlier C, Hart E, Lefort A, Ribaud P, Dromer F, Denning DW, Lortholary O (2006) Fluconazole for the management of invasive candidiasis: where do we stand after 15 years? J Antimicrob Chemother 57(3):384–410CrossRefPubMed Charlier C, Hart E, Lefort A, Ribaud P, Dromer F, Denning DW, Lortholary O (2006) Fluconazole for the management of invasive candidiasis: where do we stand after 15 years? J Antimicrob Chemother 57(3):384–410CrossRefPubMed
32.
Zurück zum Zitat Bassetti M, Righi E, Costa A, Fasce R, Molinari MP, Rosso R, Pallavicini FB, Viscoli C (2006) Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis 6:21CrossRefPubMedPubMedCentral Bassetti M, Righi E, Costa A, Fasce R, Molinari MP, Rosso R, Pallavicini FB, Viscoli C (2006) Epidemiological trends in nosocomial candidemia in intensive care. BMC Infect Dis 6:21CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Horvath JA, Dummer S (1996) The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am J Med 100(2):171–178CrossRefPubMed Horvath JA, Dummer S (1996) The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am J Med 100(2):171–178CrossRefPubMed
34.
Zurück zum Zitat Lunel FM, Mennink-Kersten MA, Ruegebrink D, van der Lee HA, Donnelly JP, Blijlevens NM, Verweij PE (2009) Value of Candida serum markers in patients with invasive candidiasis after myeloablative chemotherapy. Diagn Microbiol Infect Dis 64(4):408–415CrossRefPubMed Lunel FM, Mennink-Kersten MA, Ruegebrink D, van der Lee HA, Donnelly JP, Blijlevens NM, Verweij PE (2009) Value of Candida serum markers in patients with invasive candidiasis after myeloablative chemotherapy. Diagn Microbiol Infect Dis 64(4):408–415CrossRefPubMed
35.
Zurück zum Zitat Smith PB, Benjamin DK Jr, Alexander BD, Johnson MD, Finkelman MA, Steinbach WJ (2007) Quantification of 1,3-beta-D-glucan levels in children: preliminary data for diagnostic use of the beta-glucan assay in a pediatric setting. Clin Vaccine Immunol: CVI 14(7):924–925CrossRefPubMedPubMedCentral Smith PB, Benjamin DK Jr, Alexander BD, Johnson MD, Finkelman MA, Steinbach WJ (2007) Quantification of 1,3-beta-D-glucan levels in children: preliminary data for diagnostic use of the beta-glucan assay in a pediatric setting. Clin Vaccine Immunol: CVI 14(7):924–925CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Masuzawa S, Yoshida M, Ishibashi K, Saito N, Akashi M, Yoshikawa N, Suzuki T, Nameda S, Miura NN, Adachi Y, Ohno N (2003) Solubilized Candida cell wall beta-glucan, CSBG, is an epitope of natural human antibody. Drug Dev Res 58(2):179–189CrossRef Masuzawa S, Yoshida M, Ishibashi K, Saito N, Akashi M, Yoshikawa N, Suzuki T, Nameda S, Miura NN, Adachi Y, Ohno N (2003) Solubilized Candida cell wall beta-glucan, CSBG, is an epitope of natural human antibody. Drug Dev Res 58(2):179–189CrossRef
37.
Zurück zum Zitat Inoue K, Takano H, Koike E, Yanagisawa R, Oda T, Tamura H, Adachi Y, Ishibashi K, Ohno N (2009) Candida soluble cell wall beta-glucan facilitates ovalbumin-induced allergic airway inflammation in mice: possible role of antigen-presenting cells. Respir Res 10:68CrossRefPubMedPubMedCentral Inoue K, Takano H, Koike E, Yanagisawa R, Oda T, Tamura H, Adachi Y, Ishibashi K, Ohno N (2009) Candida soluble cell wall beta-glucan facilitates ovalbumin-induced allergic airway inflammation in mice: possible role of antigen-presenting cells. Respir Res 10:68CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Chiani P, Bromuro C, Cassone A, Torosantucci A (2009) Anti-beta-glucan antibodies in healthy human subjects. Vaccine 27(4):513–519CrossRefPubMed Chiani P, Bromuro C, Cassone A, Torosantucci A (2009) Anti-beta-glucan antibodies in healthy human subjects. Vaccine 27(4):513–519CrossRefPubMed
40.
Zurück zum Zitat Lipinski T, Fitieh A, St Pierre J, Ostergaard HL, Bundle DR, Touret N (2013) Enhanced immunogenicity of a tricomponent mannan tetanus toxoid conjugate vaccine targeted to dendritic cells via Dectin-1 by incorporating beta-glucan. J Immunol 190(8):4116–4128CrossRefPubMed Lipinski T, Fitieh A, St Pierre J, Ostergaard HL, Bundle DR, Touret N (2013) Enhanced immunogenicity of a tricomponent mannan tetanus toxoid conjugate vaccine targeted to dendritic cells via Dectin-1 by incorporating beta-glucan. J Immunol 190(8):4116–4128CrossRefPubMed
41.
Zurück zum Zitat Pan Q, Wang Q, Sun X, Xia X, Wu S, Luo F, Zhang XL (2014) Aptamer against mannose-capped lipoarabinomannan inhibits virulent Mycobacterium tuberculosis infection in mice and rhesus monkeys. Mol Ther 22(5):940–951CrossRefPubMedPubMedCentral Pan Q, Wang Q, Sun X, Xia X, Wu S, Luo F, Zhang XL (2014) Aptamer against mannose-capped lipoarabinomannan inhibits virulent Mycobacterium tuberculosis infection in mice and rhesus monkeys. Mol Ther 22(5):940–951CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Thompson GR 3rd, Bays DJ, Johnson SM, Cohen SH, Pappagianis D, Finkelman MA (2012) Serum (1->3)-beta-D-glucan measurement in coccidioidomycosis. J Clin Microbiol 50(9):3060–3062CrossRefPubMedPubMedCentral Thompson GR 3rd, Bays DJ, Johnson SM, Cohen SH, Pappagianis D, Finkelman MA (2012) Serum (1->3)-beta-D-glucan measurement in coccidioidomycosis. J Clin Microbiol 50(9):3060–3062CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Held J, Kohlberger I, Rappold E, Grawitz AB, Hacker G (2013) Comparison of (1 ->3)-beta-D-Glucan, Mannan/anti-Mannan-antibodies and Cand-Tec Candida-antigen as serum biomarkers for candidemia. Mycoses 56:17 Held J, Kohlberger I, Rappold E, Grawitz AB, Hacker G (2013) Comparison of (1 ->3)-beta-D-Glucan, Mannan/anti-Mannan-antibodies and Cand-Tec Candida-antigen as serum biomarkers for candidemia. Mycoses 56:17
Metadaten
Titel
Improved detection of deeply invasive candidiasis with DNA aptamers specific binding to (1→3)-β-D-glucans from Candida albicans
verfasst von
X.-L. Tang
Y. Hua
Q. Guan
C.-H. Yuan
Publikationsdatum
25.01.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 4/2016
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-015-2574-8

Weitere Artikel der Ausgabe 4/2016

European Journal of Clinical Microbiology & Infectious Diseases 4/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.